Alyeska Investment Group
PGEN icon

Alyeska Investment Group’s Precigen PGEN Stock Holding History

Alyeska Investment Group’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-13,690
Closed -$311K – 380
2013
Q4 		$311K Sell
13,690
-7,551
-36% -$153K 0.01% 291
2013
Q3 		$481K Buy
+21,241
New +$490K 0.02% 286

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alyeska Investment Group's PGEN Position: Q1 2014 in Review

Alyeska Investment Group sold out of Precigen (PGEN) in Q1 2014, closing a stake of 13,690 shares — an estimated $311K sold.

Alyeska Investment Group first reported a position in PGEN in Q3 2013 and held it in 2 quarters. The position peaked at $481K in Q3 2013. 100 funds tracked by Wall St. Rank hold PGEN as of Q1 2014.

  • Alyeska Investment Group reported no remaining Precigen position as of Q1 2014 after selling out during the quarter.
  • Alyeska Investment Group sold 13,690 Precigen shares in Q1 2014, an estimated $311K.
  • Alyeska Investment Group first reported a position in Precigen in Q3 2013 and held it in 2 quarters.
  • Alyeska Investment Group's Precigen position peaked at $481K in Q3 2013.
  • 100 funds tracked by Wall St. Rank held Precigen as of Q1 2014.

Based on Alyeska Investment Group's 13F filing for Q1 2014, filed 15 May 2014.